Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FHDC1 mRNA] | CTD | PMID:31150632 | (1->4)-beta-D-glucan | multiple interactions | ISO | Fhdc1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FHDC1 mRNA | CTD | PMID:36331819 | 1,1-dichloroethene | increases expression | ISO | Fhdc1 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of FHDC1 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | decreases expression | ISO | Fhdc1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of FHDC1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of FHDC1 mRNA | CTD | PMID:31614463 | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:36804509 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FHDC1 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FHDC1 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fhdc1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FHDC1 mRNA | CTD | PMID:26377647 | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of FHDC1 mRNA | CTD | PMID:30851411 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Fhdc1 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of FHDC1 mRNA | CTD | PMID:25172293 | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of FHDC1 mRNA | CTD | PMID:27685785 | 6-propyl-2-thiouracil | decreases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of FHDC1 mRNA | CTD | PMID:24780913 more ... | acetamide | increases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of FHDC1 mRNA | CTD | PMID:31881176 | amitrole | decreases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of FHDC1 mRNA | CTD | PMID:30047161 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of FHDC1 mRNA | CTD | PMID:33212167 | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of FHDC1 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of FHDC1 gene | CTD | PMID:25304211 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of FHDC1 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of FHDC1 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of FHDC1 mRNA | CTD | PMID:32234424 | bisphenol A | increases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of FHDC1 mRNA | CTD | PMID:25181051 and PMID:32145629 | cadmium atom | multiple interactions | ISO | Fhdc1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FHDC1 mRNA | CTD | PMID:37325564 | cadmium dichloride | multiple interactions | ISO | Fhdc1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FHDC1 mRNA | CTD | PMID:37325564 | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of FHDC1 mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | ISO | Fhdc1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | cefaloridine | increases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Cephaloridine results in increased expression of FHDC1 mRNA | CTD | PMID:18500788 | choline | multiple interactions | ISO | Fhdc1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FHDC1 gene | CTD | PMID:20938992 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of FHDC1 mRNA | CTD | PMID:27989131 | Didecyldimethylammonium | decreases expression | EXP | | 6480464 | didecyldimethylammonium results in decreased expression of FHDC1 mRNA | CTD | PMID:32763356 | dioxygen | multiple interactions | ISO | Fhdc1 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FHDC1 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FHDC1 mRNA | CTD | PMID:27188386 | endosulfan | increases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of FHDC1 mRNA | CTD | PMID:29391264 | folic acid | multiple interactions | ISO | Fhdc1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FHDC1 gene | CTD | PMID:20938992 | L-methionine | multiple interactions | ISO | Fhdc1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FHDC1 gene | CTD | PMID:20938992 | methimazole | decreases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of FHDC1 mRNA | CTD | PMID:30047161 | methoxychlor | affects methylation | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of FHDC1 gene | CTD | PMID:35440735 | microcystin-LR | increases methylation | EXP | | 6480464 | cyanoginosin LR results in increased methylation of FHDC1 gene | CTD | PMID:29518473 | microcystin-LR | decreases expression | EXP | | 6480464 | cyanoginosin LR results in decreased expression of FHDC1 mRNA | CTD | PMID:29518473 | oxaliplatin | decreases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | oxaliplatin results in decreased expression of FHDC1 mRNA | CTD | PMID:25729387 | oxaliplatin | multiple interactions | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of FHDC1 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of FHDC1 mRNA | CTD | PMID:35430440 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of FHDC1 mRNA | CTD | PMID:29067470 | paracetamol | decreases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of FHDC1 mRNA | CTD | PMID:33387578 | perfluorohexanesulfonic acid | decreases expression | ISO | Fhdc1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of FHDC1 mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Fhdc1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FHDC1 mRNA | CTD | PMID:36331819 | pirinixic acid | increases expression | ISO | Fhdc1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of FHDC1 mRNA | CTD | PMID:17426115 and PMID:23811191 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of FHDC1 mRNA | CTD | PMID:22714537 | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of FHDC1 mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of FHDC1 mRNA | CTD | PMID:23557933 | roxarsone | decreases expression | EXP | | 6480464 | Roxarsone results in decreased expression of INF1 mRNA | CTD | PMID:18414637 | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of FHDC1 mRNA | CTD | PMID:33725128 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FHDC1 mRNA | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | Fhdc1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of FHDC1 mRNA | CTD | PMID:37682722 | sulfadimethoxine | decreases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of FHDC1 mRNA | CTD | PMID:30047161 | tetrachloromethane | multiple interactions | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FHDC1 mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of FHDC1 mRNA | CTD | PMID:31150632 | thioacetamide | increases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of FHDC1 mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | ISO | Fhdc1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of FHDC1 mRNA | CTD | PMID:23557971 | topotecan | decreases expression | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | Topotecan results in decreased expression of FHDC1 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of FHDC1 mRNA | CTD | PMID:25729387 | troglitazone | decreases expression | ISO | Fhdc1 (Mus musculus) | 6480464 | troglitazone results in decreased expression of FHDC1 mRNA | CTD | PMID:28973697 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of FHDC1 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | Fhdc1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of FHDC1 mRNA | CTD | PMID:17963808 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of FHDC1 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FHDC1 mRNA | CTD | PMID:26272509 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FHDC1 mRNA | CTD | PMID:27188386 | vinclozolin | increases methylation | ISO | Fhdc1 (Rattus norvegicus) | 6480464 | vinclozolin results in increased methylation of FHDC1 gene | CTD | PMID:31079544 | |